SCHEMBL16322011

SCHEMBL16322011

Clc1cc2[nH]ccc2cc1-c1ccccc1Br

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 1/20 0.62
▸ AHR P35869 9/20 0.41
▸ NR4A2 P43354 2/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ CMA1 P23946 1/20 0.41
▸ F7 P08709 1/20 0.41
▸ LTA4H P09960 1/20 0.41
▸ F3 P13726 1/20 0.41
▸ GPR84 Q9NQS5 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ TRPA1 O75762 2/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ ITGB2 P05107 1/20 0.37
▸ ICAM1 P05362 1/20 0.37
▸ ITGAL P20701 1/20 0.37
▸ CA4 P22748 1/20 0.37
▸ CA6 P23280 1/20 0.37
▸ ADK P55263 1/20 0.37
▸ TRPM8 Q7Z2W7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16320988 0.94 CSNK2A1 (0.57) CSNK2A1AHRNR4A2CYP2A6CMA1
SCHEMBL10179972 0.77 CSNK2A1 (1.00) CSNK2A1AHRNR4A2CYP2A6CMA1
SCHEMBL15845492 0.75 CSNK2A1 (0.43) CSNK2A1GUSBHSD11B1GAA
SCHEMBL5148078 0.74 CSNK2A1 (0.45) CSNK2A1AHRNR4A2CYP2A6CMA1
SCHEMBL28278821 0.73 AHR (0.52) CSNK2A1AHRCYP2A6CMA1NPC1
SCHEMBL1076943 0.73 CSNK2A1 (0.85) CSNK2A1AHRNR4A2CYP2A6CMA1
SCHEMBL613747 0.72 CSNK2A1 (0.69) CSNK2A1AHRNR4A2CYP2A6CMA1
SCHEMBL16341115 0.71 AHR (0.49) CSNK2A1AHRHSD11B1MAPK14
SCHEMBL16320756 0.71 AHR (0.44) CSNK2A1AHRHSD11B1GAA
SCHEMBL16341336 0.69 AHR (0.50) CSNK2A1AHRMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-20140374724-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2014-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU CSNK2A1 4454/4885AHR 42/4885NR4A2 3278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback